Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-21-046333
Filing Date
2021-11-30
Accepted
2021-11-30 18:31:51
Documents
1
Period of Report
2021-11-24

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 15951
  Complete submission text file 0000899243-21-046333.txt   17472
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660
Business Address
Patel Samir Rashmikant (Reporting) CIK: 0001702447 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-49908 | Film No.: 211460752